Peter Gariti

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint Detecting smoking following smoking cessation treatment
    Peter Gariti
    Department of Psychiatry, Treatment Research Center, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 65:191-6. 2002
  2. pmc Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers
    Amanda Kaufmann
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104
    Addict Behav 51:93-9. 2015
  3. pmc Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking
    Peter Gariti
    Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Subst Abuse Treat 37:247-55. 2009
  4. pmc A placebo-controlled trial of modafinil for nicotine dependence
    Robert A Schnoll
    Department of Psychiatry, Abramson Cancer Center, and Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA, United States
    Drug Alcohol Depend 98:86-93. 2008
  5. ncbi request reprint Validating a dipstick method for detecting recent smoking
    Peter Gariti
    University of Pennsylvania Cancer Center Group, Philadelphia Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6178, USA
    Cancer Epidemiol Biomarkers Prev 11:1123-5. 2002
  6. pmc A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention
    David W Oslin
    Center for the Study of Addictions, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Alcohol Clin Exp Res 32:1299-308. 2008
  7. pmc Why do those who request smoking treatment fail to attend the first appointment?
    Peter Gariti
    Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Subst Abuse Treat 35:62-7. 2008
  8. ncbi request reprint A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms
    Kyle M Kampman
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 85:129-37. 2006
  9. pmc Long-term nicotine replacement therapy: a randomized clinical trial
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia
    JAMA Intern Med 175:504-11. 2015
  10. ncbi request reprint Varying results for immunoassay screening kits for cotinine level
    Arthur I Alterman
    Treatment Research Center, University of Pennsylvania School of Medicine, and Behavioral Health, Veterans Affairs Medical Center, Philadelphia 19104, USA
    Psychol Addict Behav 16:256-9. 2002

Collaborators

Detail Information

Publications14

  1. ncbi request reprint Detecting smoking following smoking cessation treatment
    Peter Gariti
    Department of Psychiatry, Treatment Research Center, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 65:191-6. 2002
    ..These findings suggest that use of urine analysis for COT may lead to more accurate but lowered measured abstinence rates...
  2. pmc Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers
    Amanda Kaufmann
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104
    Addict Behav 51:93-9. 2015
    ..Replication of this relationship in community-based samples of treatment-seeking smokers may help guide the implementation of the NMR for personalized treatment for nicotine dependence...
  3. pmc Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking
    Peter Gariti
    Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Subst Abuse Treat 37:247-55. 2009
    ..Participants with a history of heavier smoking (> or =20 cpd) and African American smokers were least likely to be smoke free at the end of the study. The study has implications for identifying the treatment needs of lighter smokers...
  4. pmc A placebo-controlled trial of modafinil for nicotine dependence
    Robert A Schnoll
    Department of Psychiatry, Abramson Cancer Center, and Annenberg Public Policy Center, University of Pennsylvania, Philadelphia, PA, United States
    Drug Alcohol Depend 98:86-93. 2008
    ..Modafinil (Provigil), a wakefulness medication shown to have efficacy for the treatment of cocaine addiction, was tested as a novel therapy for nicotine dependence in a double-blind placebo-controlled trial...
  5. ncbi request reprint Validating a dipstick method for detecting recent smoking
    Peter Gariti
    University of Pennsylvania Cancer Center Group, Philadelphia Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 6178, USA
    Cancer Epidemiol Biomarkers Prev 11:1123-5. 2002
    ..The findings have implications for investigators who accept self-reported smoking status without biochemical verification...
  6. pmc A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention
    David W Oslin
    Center for the Study of Addictions, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Alcohol Clin Exp Res 32:1299-308. 2008
    ....
  7. pmc Why do those who request smoking treatment fail to attend the first appointment?
    Peter Gariti
    Department of Psychiatry, Center for the Study of Addictions, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    J Subst Abuse Treat 35:62-7. 2008
    ..Those who kept the initial appointment were more likely to report smoking abstinence at 12 weeks. The study has implications for increasing the utilization of potentially effective treatments for smokers...
  8. ncbi request reprint A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms
    Kyle M Kampman
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3900 Chestnut Street, Philadelphia, PA 19104, USA
    Drug Alcohol Depend 85:129-37. 2006
    ..This trial evaluated the efficacy of amantadine, propranolol and their combination in cocaine dependent patients with severe cocaine withdrawal symptoms...
  9. pmc Long-term nicotine replacement therapy: a randomized clinical trial
    Robert A Schnoll
    Department of Psychiatry, University of Pennsylvania, Philadelphia
    JAMA Intern Med 175:504-11. 2015
    ..This decision was based in part on data showing increased efficacy for 24 weeks of treatment. Few studies have examined whether the use of nicotine patches beyond 24 weeks provides additional therapeutic benefit...
  10. ncbi request reprint Varying results for immunoassay screening kits for cotinine level
    Arthur I Alterman
    Treatment Research Center, University of Pennsylvania School of Medicine, and Behavioral Health, Veterans Affairs Medical Center, Philadelphia 19104, USA
    Psychol Addict Behav 16:256-9. 2002
    ..The findings indicate that use of screening ELISA/EIA for urine cotinine can detect unreported cases of smoking in former patients, but that care is needed in selecting a laboratory for conducting these tests...
  11. ncbi request reprint Adding a nicotine blocking agent to cigarette tapering
    Peter Gariti
    Treatment Research Center, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    J Subst Abuse Treat 27:17-25. 2004
    ..Biochemically confirmed abstinence rates at followups did not differ between treatment groups (AD&C = 10%, 13%, 10% vs. PD&C = 3%, 10%, 13%). There is not enough evidence to suggest a Stage II trial...
  12. ncbi request reprint Retrospective study: influence of menstrual cycle on cue-induced cigarette craving
    Teresa R Franklin
    Addiction Treatment Research Center, Department of Psychiatry, University of Pennsylvania, Veteran s Administration Hospital of Philadelphia, USA
    Nicotine Tob Res 6:171-5. 2004
    ..05). The suppressed craving response in FFemales suggests an influence of cycle phase on cue-induced craving...
  13. ncbi request reprint Nicotine intervention during detoxification and treatment for other substance use
    Peter Gariti
    Philadelphia Veterans Affairs Medical Center, Philadelphia, PA 19104, USA
    Am J Drug Alcohol Abuse 28:671-9. 2002
    ..The groups did not differ on abstinence from nonnicotine addictive substances. Smoking cessation treatment in substance users undergoing detoxification resulted in little or no smoking cessation advantage...
  14. ncbi request reprint Determining the need for gender-specific chemical dependence treatment: assessment of treatment variables
    Linda S Cook
    The School of Nursing and the Health Sciences, Texas A and M University Corpus Christi, Corpus Christi, TX 78412, USA
    Am J Addict 14:328-38. 2005
    ..Results demonstrated significant gender differences in differentiation of self (p < .005) and coping styles (p < .02) but no significant differences in anxiety or depression...